Neuropeptides
Volume 44, Issue 5 , Pages 373-383, October 2010

The vasoactive intestinal peptide-receptor system is involved in human glioblastoma cell migration

Institut de Physiologie et Biologie Cellulaires, Université de Poitiers, CNRS, 40 Avenue du Recteur Pineau, Poitiers F-86022, France

Received 16 December 2009; accepted 12 June 2010. published online 20 July 2010.

Abstract 

Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor in adults. This cancer has an infiltrative nature and the median survival of patients is about one year. Vasoactive intestinal peptide (VIP) belongs to a structurally related family of polypeptides and is a major regulatory factor in the central and peripheral nervous systems. VIP regulates proliferation of astrocytes and of numerous cancer cell lines and modulates migration in prostatic and colonic cancer cell lines. Little is known about the involvement of VIP and its receptors (VIP-receptor system) in proliferation or migration of GBM cells. The effects of VIP, PACAP and of synthetic VIP antagonists were tested in two human GBM cell lines, M059K and M059J, established from two different parts of a single tumor. In these cells, the data revealed that the VIP-receptor system did not affect proliferation but controlled cell migration. Indeed, in M059K cells which express components of the VIP receptor system, the VIP receptor antagonists and a PACAP antibody enhanced migration. The VIP receptor antagonists increased generation of typical migration-associated processes: filopodia and lamellipodia, and activation of Rac1 and Cdc42 GTPases. Reciprocally, in M059J cells which poorly express the VIP-receptor system, treatments with the agonists VIP and PACAP resulted in decreased cell migration. Furthermore, the peptides appeared to act through a subclass of binding sites displaying an uncommon very high affinity for these ligands. Taken together, these observations suggest that components of the VIP-receptor system negatively regulate cell migration, thus showing potential anti-oncogenic properties.

Abbreviations: VIP, vasoactive intestinal peptide, PACAP, pituitary adenylate cyclase-activating polypeptide, DMEM, Dulbecco’s modified Eagle’s medium, GAPDH, glyceraldehyde-3-phosphate dehydrogenase, PCR, polymerase chain reaction, PBS, phosphate-buffered saline, DTT, dithiothreitol, PMSF, phenylmethylsulfonyl fluoride, BSA, bovin serum albumin, ECL, electrochemiluminescence, TFA, trifluoroacetic acid, OD, optical density, MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, DAB, diaminobenzidine, PAK-PBD, p21-activated kinase-PAK binding domain

Keywords: VIP receptors, Glioblastoma cell lines, Proliferation, Migration, Actin cytoskeleton, Small GTPases

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4179(10)00067-3

doi:10.1016/j.npep.2010.06.003

Neuropeptides
Volume 44, Issue 5 , Pages 373-383, October 2010